IGF2BP3 and cancer: Previous study has systematically characterized the molecular alterations and clinical relevance of 20 m6A RNA regulators across 33 cancer types, and they found that m6A regulators were found to be potentially useful for prognostic stratification and identified IGF2BP3 as a potential oncogene across multiple cancer types (36).